Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.
Loading...
Identifiers
Publication date
Authors
Trives Folguera, Laura
Cobo Ibáñez, María Tatiana
Vergara Dangond, Cristina
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Choroidal thickness (CT) varies with systemic inflammatory activity in diseases such as spondyloarthritis, suggesting its potential role as a biomarker. This study aimes to evaluate changes in CT in patients recently diagnosed with Polymyalgia Rheumatica (PMR) who are undergoing corticosteroid therapy, over a six-month follow-up period. This is a prospective, observational, longitudinal pilot study including 20 patients with recent PMR diagnosis from two centres.
Description
Keywords
Bibliographic reference
Trives-Folguera, L., Muñoz-Fernández, S., Esteban-Ortega, M. D. M., Coca-Serrano, R., Cobo-Ibañez, T., Vergara-Dangond, C., Romero-Bogado, L., De La Cámara-Fernández, I., Richi, P., Paredes, M. B., Esteban-Vazquez, A., Acosta, A. V., Najera, G. C., José, M. A. S., González-Martín, J. J., Franco Gomez, K. N., Bogas Schay, P., Shukair Harb, T., Thuissard-Vasallo, I., & Steiner, M. (2025). Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica. Frontiers in Medicine, 12, 1689327. https://doi.org/10.3389/fmed.2025.1689327
Editor's version
https://doi.org/10.3389/fmed.2025.1689327Type of document
Collections
La licencia de este ítem se describe como Attribution 4.0 International